Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas

Journal of Neuro-Oncology

Volumn 106, Issue 1, 2012, Pages 43-51

  Wang, Xiao Bing ^a   Tian, Xiao Ying ^b   Li, Yang ^c   Li, Bin ^c   Li, Zhi ^c  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Angiogenesis; Glioma; Macrophage migration inhibitory factor (MIF); Prognosis; Recurrence

Indexed keywords

INTERLEUKIN 8; LOMUSTINE; MACROPHAGE MIGRATION INHIBITION FACTOR; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; AGED; ANAPLASTIC OLIGOASTROCYTOMA; ARTICLE; ASTROCYTOMA; CANCER GRADING; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPENDYMOMA; FEMALE; FIBRILLARY ASTROCYTOMA; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRATUMORAL MICROVESSEL DENSITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OLIGODENDROGLIOMA; OVERALL SURVIVAL; PILOCYTIC ASTROCYTOMA; PLEOMORPHIC XANTHOASTROCYTOMA; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SURVIVAL; TUMOR RECURRENCE; TUMOR VASCULARIZATION;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CAPILLARIES; CHILD; FEMALE; FOLLOW-UP STUDIES; GENETIC MARKERS; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; KAPLAN-MEIER ESTIMATE; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL; YOUNG ADULT;

EID: 83055173065     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0640-3     Document Type: Article

References (40)

1. G Sciume A Santoni G Bernardini 2010 Chemokines and glioma: invasion and more J Neuroimmunol 224 8 12 20656128 10.1016/j.jneuroim.2010.05.019 1:CAS:528:DC%2BC3cXptlehtLY%3D
2. JP Bach B Rinn B Meyer R Dodel M Bacher 2008 Role of MIF in inflammation and tumorigenesis Oncology 75 127 133 18791328 10.1159/000155223 1:CAS:528:DC%2BD1cXhsVKju7%2FF
3. M Krockenberger JB Engel J Kolb Y Dombrowsky SF Hausler N Kohrenhagen J Dietl J Wischhusen A Honig 2010 Macrophage migration inhibitory factor expression in cervical cancer J Cancer Res Clin Oncol 136 651 657 19915866 10.1007/s00432-009-0702-5 1:CAS:528:DC%2BC3cXjs1ejtb0%3D
4. BE Rendon T Roger I Teneng M Zhao Y Al-Abed T Calandra RA Mitchell 2007 Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor J Biol Chem 282 29910 29918 17709373 10.1074/jbc.M704898200 1:CAS:528:DC%2BD2sXhtFagtbrJ (Pubitemid 350035289)
5. X Xu B Wang C Ye C Yao Y Lin X Huang Y Zhang S Wang 2008 Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer Cancer Lett 261 147 157 18171602 10.1016/j.canlet.2007.11.028 1:CAS:528:DC%2BD1cXitlemt7c%3D (Pubitemid 351253721)
6. E Hira T Ono DK Dhar ON El-Assal Y Hishikawa A Yamanoi N Nagasue 2005 Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma Cancer 103 588 598 15612021 10.1002/cncr.20818 1:CAS:528:DC%2BD2MXhs1amsbc%3D
7. GQ Li J Xie XY Lei L Zhang 2009 Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3 K/Akt pathway World J Gastroenterol 15 5541 5548 19938192 10.3748/wjg.15.5541 1:CAS:528: DC%2BD1MXhsFSmtbrE
8. H Lue M Thiele J Franz E Dahl S Speckgens L Leng G Fingerle-Rowson R Bucala B Lüscher J Bernhagen 2007 Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity Oncogene 26 5046 5059 17310986 10.1038/sj.onc.1210318 1:CAS:528:DC%2BD2sXosVemu7k%3D (Pubitemid 47206949)
9. JP Bach OD MA M Balzer-Geldsetzer B Meyer R Dodel M Bacher 2009 The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors Cancer 115 2031 2040 19326434 10.1002/cncr.24245 1:CAS:528: DC%2BD1MXlvFOiu7w%3D
10. DS Yu JC Lin DS Hsieh SY Chang CF Lee 2006 Modulation of MDR-1 gene by MIF and GSTpi with drug resistance generation in hormone independent prostate cancer Arch Androl 52 283 291 16728344 10.1080/01485010600630116 1:CAS:528:DC%2BD28Xms1Oltrs%3D (Pubitemid 44264741)
11. H Legendre C Decaestecker N Nagy A Hendlisz MP Schüring I Salmon HJ Gabius JC Pector R Kiss 2003 Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers Mod Pathol 16 491 504 12748256 10.1097/01.MP.0000068235.45178.C1 (Pubitemid 36618470)
12. KL Meyer-Siegler MA Bellino M Tannenbaum 2002 Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma Cancer 94 1449 1456 11920501 10.1002/cncr.10354 1:CAS:528:DC%2BD38XisVWmtLw%3D (Pubitemid 34212639)
13. Y Ren S Law X Huang PY Lee M Bacher G Srivastava J Wong 2005 Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma Ann Surg 242 55 63 15973102 10.1097/01.sla.0000168555.97710.bb (Pubitemid 40917968)
14. ES White KR Flaherty S Carskadon A Brant MD Iannettoni J Yee MB Orringer DA Arenberg 2003 Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis Clin Cancer Res 9 853 860 12576459 1:CAS:528:DC%2BD3sXhtVKktrw%3D (Pubitemid 36182624)
15. M Bacher J Schrader N Thompson K Kuschela D Gemsa G Waeber J Schlegel 2003 Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme Am J Pathol 162 11 17 12507885 10.1016/S0002-9440(10)63793-5 1:CAS:528:DC%2BD3sXlsFyrtg%3D%3D (Pubitemid 36041985)
16. C Munaut J Boniver JM Foidart M Deprez 2002 Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression Neuropathol Appl Neurobiol 28 452 460 12445161 10.1046/j.1365-2990.2002.00416.x 1:CAS:528: DC%2BD38Xps1yjtLg%3D (Pubitemid 35425598)
17. M Nagy D Schulz-Ertner M Bischof T Welzel H Hof J Debus SE Combs 2009 Long-term outcome of postoperative irradiation in patients with newly diagnosed WHO grade III anaplastic gliomas Tumori 95 317 324 19688970
18. C Nieder N Andratschke N Wiedenmann R Busch AL Grosu M Molls 2004 Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome? Strahlenther Onkol 180 401 407 15241527 10.1007/s00066-004-1220-7 (Pubitemid 39207378)
19. A Thelen A Scholz C Benckert M Schröder W Weichert B Wiedenmann P Neuhaus S Jonas 2008 Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma J Gastroenterol 43 959 966 19107340 10.1007/s00535-008-2255-9
20. DJ Waugh C Wilson 2008 The interleukin-8 pathway in cancer Clin Cancer Res 14 6735 6741 18980965 10.1158/1078-0432.CCR-07-4843 1:CAS:528: DC%2BD1cXhtlens7vL
21. L Xu PS Pathak D Fukumura 2004 Hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase signling pathways contributes to expression of interleukin 8 in human ovarian carcinoma cells Clin Cancer Res 10 701 707 14760093 10.1158/1078-0432.CCR-0953-03 1:CAS:528:DC%2BD2cXovVKjtA%3D%3D (Pubitemid 38174009)
22. PJ Maxwell R Gallagher A Seaton 2007 HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells Oncogene 26 7333 7345 17533374 10.1038/sj.onc.1210536 1:CAS:528:DC%2BD2sXhtlWjtrzL (Pubitemid 350115971)
23. B Liao BL Zhong Z Li XY Tian Y Li B Li 2010 Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma J Surg Oncol 102 844 851 20872800 10.1002/jso.21728
24. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) Astrocytic tumors. In: Louis DN (ed) WHO classification of tumor of the central nervous system, 4th edn. IARC Press, Lyon, pp 14-49
25. R Stupp WP Mason MJ van den Bent, et al. 2005 Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma N Engl J Med 352 987 996 15758009 10.1056/NEJMoa043330 1:CAS:528:DC%2BD2MXit1Wksbk%3D (Pubitemid 40349501)
26. WK Yung MD Prados R Yaya-Tur 1999 Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group J Clin Oncol 17 2762 2771 10561351 1:CAS:528:DyaK1MXmtlWru7s%3D (Pubitemid 29415233)
27. J Glass FH Hochberg ML Gruber DN Louis D Smith B Rattner 1992 The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy J Neurosurg 76 741 745 1564535 10.3171/jns.1992.76.5.0741 1:STN:280:DyaK383is1yitQ%3D%3D
28. B Li-juan L Bing L Zhi L Yang L Ying-jie 2009 Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression Pathol Res Pract 205 828 837 19625133 10.1016/j.prp.2009.06.016
29. LQ Xie LJ Bian Z Li Y Li YJ Liang 2010 Co-elevated expression of hepatocyte growth factor and Interleukin-8 contributes to poor prognosis of patients with primary nasopharyngeal carcinoma Oncol Rep 23 141 150 19956874 10.3892/or-00000813 1:CAS:528:DC%2BC3cXoslGgsw%3D%3D
30. L Rubio JS Burgos C Morera FJ Vera-Sempere 2000 Morphometric study of tumor angiogenesis as a new prognostic factor in nasopharyngeal carcinoma patients Pathol Oncol Res 6 210 216 11033462 10.1007/BF03032375 1:STN:280:DC%2BD3M%2FmtFeltg%3D%3D
31. JD Hudson MA Shoaibi R Maestro A Carnero GJ Hannon DH Beach 1999 A proinflammatory cytokine inhibits p53 tumor suppressor activity J Exp Med 190 1375 1382 10562313 10.1084/jem.190.10.1375 1:CAS:528:DyaK1MXnsVams7w%3D
32. RA Mitchell CN Metz T Peng R Bucala 1999 Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action J Biol Chem 274 18100 18106 10364264 10.1074/jbc.274.25. 18100 1:CAS:528:DyaK1MXktVylt7o%3D (Pubitemid 29283341)
33. FG Barker 2nd RL Davis SM Chang MD Prados 1996 Necrosis as a prognostic factor in glioblastoma multiforme Cancer 77 1161 1166 8635139 10.1002/(SICI)1097-0142(19960315)77:6<1161::AID-CNCR24>3.0.CO;2-Z (Pubitemid 26080909)
34. J Chesney C Metz M Bacher T Peng A Meinhardt R Bucala 1999 An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma Mol Med 5 181 191 10404515 1:CAS:528: DyaK1MXktVaqtbc%3D (Pubitemid 29252666)
35. Y Ren HT Tsui RT Poon IO Ng Z Li Y Chen G Jiang C Lau WC Yu M Bacher ST Fan 2003 Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma Int J Cancer 107 22 29 12925952 10.1002/ijc.11287 1:CAS:528:DC%2BD3sXntlKmtrw%3D (Pubitemid 37100081)
36. B Sun J Nishihira T Yoshiki M Kondo Y Sato F Sasaki S Todo 2005 Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway Clin Cancer Res 11 1050 1058 15709171 1:CAS:528:DC%2BD2MXht1yntrs%3D (Pubitemid 40175753)
37. T Cacev S Radosevic S Krizanac S Kapitanovic 2008 Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression Carcinogenesis 29 1572 1580 18628251 10.1093/carcin/bgn164 1:CAS:528:DC%2BD1cXhtVSis7zN
38. DJ Caruso AJ Carmack VB Lokeshwar RC Duncan MS Soloway BL Lokeshwar 2008 Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence Clin Cancer Res 14 4111 4118 18593988 10.1158/1078-0432.CCR-08-0738 1:CAS:528:DC%2BD1cXnvFylu78%3D
39. S Onodera J Nishihira Y Koyama T Majima Y Aoki H Ichiyama T Ishibashi A Minami 2004 Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta Arthritis Rheum 50 1437 1447 15146413 10.1002/art.20190 1:CAS:528:DC%2BD2cXkvFykurY%3D (Pubitemid 38608065)
40. B Liao BL Zhong Z Li XY Tian Y Li B Li 2010 Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma J Surg Oncol 102 844 851 20872800 10.1002/jso.21728